Dr. Samuel Moulton, M.D. Orthopaedic Surgery - Sports Medicine Medicare: Medicare Enrolled Practice Location: 510 8th Ave Ne Ste 200, Issaquah, WA 98029 Phone: 425-392-3030 Fax: 425-392-2564 |
Dr. Christopher John Wahl, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 510 8th Ave Ne Ste 200, Issaquah, WA 98029 Phone: 425-392-3030 Fax: 425-392-2564 |
Dr. Ryan James Nathe, M.D. Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 510 8th Ave Ne Ste 200, Issaquah, WA 98029 Phone: 425-392-3030 Fax: 425-392-2564 |
Dr. Tyler J Nathe, MD Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 510 8th Ave Ne Ste 200, Issaquah, WA 98029 Phone: 425-392-3030 Fax: 425-392-2564 |
Alexander H. Arzeno, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 510 8th Ave Ne Ste 200, Issaquah, WA 98029 Phone: 425-392-3030 Fax: 425-392-2564 |
Dr. Michael J Sailer, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 510 8th Ave Ne Ste 200, Issaquah, WA 98029 Phone: 425-392-3030 Fax: 425-392-2564 |
News Archive
An international team of researchers have developed a low-cost sensor made from semiconducting plastic that can be used to diagnose or monitor a wide range of health conditions, such as surgical complications or neurodegenerative diseases.
A number of groups in Sweden, including public service broadcasters Sveriges Television (SVT), and Sveriges Radio, are providing their country with the latest coverage of the coronavirus situation. A new survey shows that 80% of Swedes have moderate to high levels of trust in the public reporting and their government officials.
In November 2010, an online gaming company called ActiVision released Call of Duty: Black Ops, a violent, first-person shooter game compatible with a variety of gaming devices. The video game sold 5.6 million copies within 24 hours of its release, and it earned a record-breaking $650 million in its first five days. Six weeks later, the game had exceeded $1 billion in sales.
Regenerative medicine company Mesoblast Limited (ASX: MSB) today announced that it has received regulatory clearance from the Singapore Health Sciences Authority (HSA) to commence the first Phase 2 trial of its proprietary allogeneic (off-the-shelf) adult stem cell therapy for patients with proliferation of leaky blood vessels in the eyes – neovascular ("wet") Age-related Macular Degeneration (AMD).
› Verified 7 days ago